Clinical Trials Sponsored by Otsuka Frankfurt Research Institute GmbH

Total 144 results

Otsuka Frankfurt Research Institute GmbH

Unknown

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

SIADH | Non-SIADH Hyponatremia | Non-Hyponatremia

Denmark, Germany, Italy, Norway, Spain, Sweden, United Kingdom
Otsuka Frankfurt Research Institute GmbH

Completed

ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

Ulcerative Colitis
Otsuka Frankfurt Research Institute GmbH

Completed

CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis

Ulcerative Colitis

Germany
Otsuka Frankfurt Research Institute GmbH

Completed

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Otsuka Frankfurt Research Institute GmbH

Completed

A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions

Intermittent Claudication

Germany
Otsuka Frankfurt Research Institute GmbH

Completed

Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)

Ulcerative Colitis
Otsuka Beijing Research Institute

Recruiting

Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Health

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder

China
Otsuka Beijing Research Institute

Completed

A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers

Chinese Healthy Volunteers

China
Otsuka Beijing Research Institute

Completed

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Type 2 Diabetes Mellitus | Arteriosclerosis Obliterans

China
Otsuka Beijing Research Institute

Recruiting

PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

China
Otsuka Beijing Research Institute

Active, not recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia

China
Otsuka Beijing Research Institute

Completed

OPC-61815 in Healthy Chinese Male Subjects

Healthy Adult Male

China
Otsuka Beijing Research Institute

Terminated

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

Major Depressive Disorder

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Unknown

To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject

Severe Hypercholesterolemia

China
Otsuka Beijing Research Institute

Completed

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Singapore
Otsuka Beijing Research Institute

Completed

Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

Hyperlipidemia

China
Otsuka Beijing Research Institute

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Diabetic Nephropathy

China
Otsuka Beijing Research Institute

Completed

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Recruiting

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

Open Angle Glaucoma or Ocular Hypertension

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

Tourette Syndrome

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema

Cardiac Edema

China
Otsuka Beijing Research Institute

Completed

Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

Atherosclerosis Cerebral Infarction

China
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

Hypovolemic Hyponatremia

China
Otsuka Beijing Research Institute
Zhejiang Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute
Zhejiang Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke

Cerebral Infarction

China
ViMREX GmbH
Frankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus...

Active, not recruiting

Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN) (DelVIN)

Vulvar Intraepithelial Neoplasia Grade 2 | Vulvar Intraepithelial Neoplasia Grade 3

Germany
AIO-Studien-gGmbH
Sanofi; Institut für Klinisch-Onkologische Forschung (IKF) Frankfurt

Completed

mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer

Rectal Cancer | Rectosigmoid Cancer

Germany
University Clinic Frankfurt
Institut für Kardiovaskuläre Physiologie, Vascular Research Center

Unknown

Vitamin D Effect on Subarachnoid Hemorrhage

Vitamin D Deficiency

Germany
Lawson Health Research Institute
Otsuka Pharmaceutical Co., Ltd.

Completed

The Effects of Cranberry Juice on Bacterial Adhesion

Bacterial Vaginosis | Oxaluria
ISAR-M GmbH
CRI-The Clinical Research Institute GmbH

Recruiting

A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product (HEDOS)

Thyroid

Germany
ResMed
CRI-The Clinical Research Institute GmbH

Active, not recruiting

HomeVent ( Connect) Registry: EU COPD Home NIV Registry (HOmeVent)

Chronic Obstructive Pulmonary Disease

Germany
ResMed
CRI-The Clinical Research Institute GmbH

Completed

Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure (Serve-HF)

Heart Failure | Sleep Disordered Breathing

Germany, Netherlands, Australia, Denmark, France, United Kingdom, Switzerland, Norway, Finland, Sweden, Czechia
Ottawa Hospital Research Institute
Stryker Trauma GmbH

Completed

A Comparison of a Resurfacing Hip System to Standard Total Hip Arthroplasty

Osteoarthritis

Canada
Ottawa Hospital Research Institute
Stryker Trauma GmbH

Completed

RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement (RCT)

Osteoarthritis | Arthroplasty | Hip Joint

Canada
Lawson Health Research Institute
UCB Pharma GmbH

Terminated

Lacosamide IV and EEG/EKG (LIVE) Study (LIVE)

Focal Epilepsy

Canada
Ottawa Hospital Research Institute
Stryker Trauma GmbH

Completed

Motion Analysis of EMP Knee Versus Posterior Stabilized Knee Arthroplasty for Osteoarthritis

Arthropathy of Knee Joint

Canada
Physeon GmbH
Regulatory Clinical Research Institute (RCRI)

Terminated

Veinplicity for Improved Venous Access: The VIVA Trial

Difficult-to-access Veins for Intravenous Cannulation

United States

Clinical Trials Sponsored by Otsuka Frankfurt Research Institute GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations